Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1276025.RAMYxOopYgrH2-mMer_0LSJOKl1a2AoZ062yjB1P4Q2tU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1276025.RAMYxOopYgrH2-mMer_0LSJOKl1a2AoZ062yjB1P4Q2tU130_assertion type Assertion NP1276025.RAMYxOopYgrH2-mMer_0LSJOKl1a2AoZ062yjB1P4Q2tU130_head.
- NP1276025.RAMYxOopYgrH2-mMer_0LSJOKl1a2AoZ062yjB1P4Q2tU130_assertion description "[Our results suggest that TRIM16 is a potential pharmacologic target for the treatment of NSCLC and promotion TRIM16 expression might represent a novel strategy to NSCLC metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1276025.RAMYxOopYgrH2-mMer_0LSJOKl1a2AoZ062yjB1P4Q2tU130_provenance.
- NP1276025.RAMYxOopYgrH2-mMer_0LSJOKl1a2AoZ062yjB1P4Q2tU130_assertion evidence source_evidence_literature NP1276025.RAMYxOopYgrH2-mMer_0LSJOKl1a2AoZ062yjB1P4Q2tU130_provenance.
- NP1276025.RAMYxOopYgrH2-mMer_0LSJOKl1a2AoZ062yjB1P4Q2tU130_assertion SIO_000772 25843803 NP1276025.RAMYxOopYgrH2-mMer_0LSJOKl1a2AoZ062yjB1P4Q2tU130_provenance.
- NP1276025.RAMYxOopYgrH2-mMer_0LSJOKl1a2AoZ062yjB1P4Q2tU130_assertion wasDerivedFrom befree-2016 NP1276025.RAMYxOopYgrH2-mMer_0LSJOKl1a2AoZ062yjB1P4Q2tU130_provenance.
- NP1276025.RAMYxOopYgrH2-mMer_0LSJOKl1a2AoZ062yjB1P4Q2tU130_assertion wasGeneratedBy ECO_0000203 NP1276025.RAMYxOopYgrH2-mMer_0LSJOKl1a2AoZ062yjB1P4Q2tU130_provenance.